Skip to main content
Erschienen in: Journal of Cancer Survivorship 6/2018

04.09.2018

Barriers to physical activity: a study of academic and community cancer survivors with pain

verfasst von: Sally A. D. Romero, Justin C. Brown, Joshua M. Bauml, Jennifer L. Hay, Q. Susan Li, Roger B. Cohen, Jun J. Mao

Erschienen in: Journal of Cancer Survivorship | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Despite the numerous benefits of physical activity (PA) for patients with cancer, many cancer survivors report challenges to participating in PA. The objectives of this study were (1) to assess barriers to PA and (2) to examine participant characteristics associated with modifiable barriers to PA among cancer survivors with pain.

Methods

We conducted a cross-sectional survey study at one academic medical center and 11 community hospitals. Participants completed the 12-item Physical Activity Barriers After Cancer (PABAC) instrument (Cronbach’s alpha = 0.75). Multivariable regression models examined participant characteristics associated with PABAC scores with a higher score indicating more barriers to PA.

Results

Among 662 survivors, 67% had moderate or severe pain (rating 4 or greater on a scale of 0 to 10). Seventy-five percent of survivors did not meet the American Cancer Society PA recommendations on average, and these individuals had higher mean PABAC scores (beta coefficient (β) = 2.02, 95% confidence interval (CI) 0.96–3.09, p < 0.001). In adjusted analyses, cancer survivors who were non-white (β = 1.55, 0.28–2.82, p = 0.02), treated at a community hospital (β = 1.07, 0.09–2.05, p = 0.03), had surgery (β = 1.69, 0.69–2.69, p = 0.001), or within 12 months of diagnosis (β = 1.15, 0.20–2.10, p = 0.02) reported greater barriers to PA.

Conclusions

The majority of cancer survivors with pain are not adequately participating in PA. Key demographic and clinical characteristics are associated with survivors’ barriers.

Implications for Cancer Survivors

Efforts to overcome specific barriers are needed to promote PA after a cancer diagnosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat CDC. Cancer survivors--United States, 2007. MMWR Morb Mortal Wkly Rep. 2011;60(9):269–72. CDC. Cancer survivors--United States, 2007. MMWR Morb Mortal Wkly Rep. 2011;60(9):269–72.
4.
Zurück zum Zitat Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, et al. Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw. 2015;13(8):1012–39.CrossRef Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, et al. Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw. 2015;13(8):1012–39.CrossRef
6.
Zurück zum Zitat Swarm RA, Abernethy AP, Anghelescu DL, Benedetti C, Buga S, Cleeland C, et al. Adult cancer pain. J Natl Compr Cancer Netw. 2013;11(8):992–1022.CrossRef Swarm RA, Abernethy AP, Anghelescu DL, Benedetti C, Buga S, Cleeland C, et al. Adult cancer pain. J Natl Compr Cancer Netw. 2013;11(8):992–1022.CrossRef
12.
Zurück zum Zitat Ottenbacher A, Yu M, Moser RP, Phillips SM, Alfano C, Perna FM. Population estimates of meeting strength training and aerobic guidelines, by gender and cancer survivorship status: findings from the health information National Trends Survey (HINTS). J Phys Act Health. 2015;12(5):675–9. https://doi.org/10.1123/jpah.2014-0003.CrossRefPubMed Ottenbacher A, Yu M, Moser RP, Phillips SM, Alfano C, Perna FM. Population estimates of meeting strength training and aerobic guidelines, by gender and cancer survivorship status: findings from the health information National Trends Survey (HINTS). J Phys Act Health. 2015;12(5):675–9. https://​doi.​org/​10.​1123/​jpah.​2014-0003.CrossRefPubMed
14.
Zurück zum Zitat Blaney JM, Lowe-Strong A, Rankin-Watt J, Campbell A, Gracey JH. Cancer survivors' exercise barriers, facilitators and preferences in the context of fatigue, quality of life and physical activity participation: a questionnaire-survey. Psychooncology. 2013;22(1):186–94. https://doi.org/10.1002/pon.2072.CrossRefPubMed Blaney JM, Lowe-Strong A, Rankin-Watt J, Campbell A, Gracey JH. Cancer survivors' exercise barriers, facilitators and preferences in the context of fatigue, quality of life and physical activity participation: a questionnaire-survey. Psychooncology. 2013;22(1):186–94. https://​doi.​org/​10.​1002/​pon.​2072.CrossRefPubMed
28.
Zurück zum Zitat Parks SE, Housemann RA, Brownson RC. Differential correlates of physical activity in urban and rural adults of various socioeconomic backgrounds in the United States. J Epidemiol Community Health. 2003;57(1):29–35.CrossRefPubMedPubMedCentral Parks SE, Housemann RA, Brownson RC. Differential correlates of physical activity in urban and rural adults of various socioeconomic backgrounds in the United States. J Epidemiol Community Health. 2003;57(1):29–35.CrossRefPubMedPubMedCentral
Metadaten
Titel
Barriers to physical activity: a study of academic and community cancer survivors with pain
verfasst von
Sally A. D. Romero
Justin C. Brown
Joshua M. Bauml
Jennifer L. Hay
Q. Susan Li
Roger B. Cohen
Jun J. Mao
Publikationsdatum
04.09.2018
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 6/2018
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-018-0711-y

Weitere Artikel der Ausgabe 6/2018

Journal of Cancer Survivorship 6/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.